DOCSLIB.ORG

Idiopathic Intracranial Hypertension: a True Diagnosis of Exclusion By

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Idiopathic Intracranial Hypertension: a True Diagnosis of Exclusion By Idiopathic Intracranial Hypertension: A True Diagnosis of Exclusion By: Rodney Jacob Gunn, OD [email protected] (714) 553-5449 Group Health Cooperative Optometry Resident Tacoma, WA Abstract (35 words): Idiopathic intracranial hypertension is a disorder of increased CSF pressure of unknown cause. This case demonstrates a 46-year-old obese female with papilledema, normal imaging studies and lumbar puncture whose symptoms improved with acetazolamide. Outline: I. Case History: - Patient Demographics / Chief complaint: 46-year-old white female was referred to the eye clinic for confirmation of Papilledema. She presented earlier that day to urgent care complaining of a pulsatile headache and nausea for the past 3-4 weeks. She also reported vertigo that’s occurred on and off for the past year. She denied symptoms of tinnitus, photophobia, and double vision. - Ocular History: Compound myopic astigmatism corrected with soft toric contact lenses Early Presbyopia corrected with +1.50 over the counter readers. - Medical history: Hypertension Fibromyalgia Anxiety Benign neoplasm of colon - Medications: Triamterene-Hydrochlorothiazide 75/50mg Duloxetine 60mg Amitriptyline 100mg at bedtime Calcium Carbinate 500mg Cetirizine as needed II. Pertinent Findings - Clinical Height: 5’5 Weight: 270 lb. Body Mass Index: 45.02 Blood Pressure: 132/80 Visual Acuity Corrected with Contact Lenses: OD: 20/20 OS: 20/20 Color Vision Normal by Pseudoisochromatic Plates OD and OS Pupils equal round responsive to light with no afferent pupillary defect - Physical Anterior segment health unremarkable Dilated fundus exam remarkable for bilateral nasal disc edema OS > OD (As shown below) Figure 1: Stereo photographs of the right optic nerve with nasal optic nerve edema. Figure 2: Stereo photographs of the left optic nerve nasal optic nerve edema. - Laboratory Studies Complete Blood Count with Differential showed slightly elevated white blood cells, neutrophils, and monocytes deemed to be acceptable by her primary care doctor. - Radiology Studies Cat Scan was unremarkable. MRI/MRV: As shown below. Figure3: Top left: Sagittal T1 image of the brain. Top Right: Magnetic resonance venogram. Bottom Left: Axial T1 illustrating the globes and optic nerve. Bottom Right: Axial T2 illustrating globes and optic nerve. - Others Lumbar Puncture: Opening Pressure 70mm H2O Approximately 9 cc of clear CSF fluid was collected, laboratory analysis showed normal content with no cell growth on cultures. Humphrey Visual Field 30-2SS OD: generalized depression without specific pattern, MD -4.13, PSD 2.96 OS: generalized depression (more dense than OD) with a cluster of superior peripheral points. MD -5.15 / PSD 3.41 (Fields will be available to be displayed for poster) III. Differential Diagnosis - Primary/Leading Idiopathic Intracranial Hypertension - Others Bilateral optic neuritis Papilledema from a secondary cause including hydrocephalus, venous sinus thrombosis, medications, tumor, or others… IV. Diagnosis and discussion After having ruled out all other causes of papilledema this patient was diagnosed with Idiopathic Intracranial hypertension (IIH). IIH previously called Pseudotumor cerebri is a diagnosis of exclusion. It’s most commonly seen in obese females of childbearing age. The signs and symptoms of IIH include symptoms of intracranial hypertension with out localizing signs, no evidence of deformity or obstruction of the ventricular system and neurodiagnostic studies are otherwise normal except for increased intracranial pressure1. This patient met all these criteria except the definition of increased intracranial pressure, defined as >200mmH2O or 250 mmH2O in obese individuals. Despite this the attending Neurologist decided to continue with the diagnosis of IIH. V. Treatment, Management Weight loss Acetazolamide - Treatment and response to treatment Treatment generally depends on the course of IIH which can be highly variable and is structured around relieving symptoms and preventing vision loss. The treatment is generally weight loss, high dose carbonic anhydrase inhibitors, and serial lumbar punctures. Some patients may see improvement in their symptoms after the diagnostic lumbar puncture2. Our patient reported an improvement in her symptoms after a week of acetazolamide, and is continuing to be followed for her visual field and papilledema. Acetazolamide is a common treatment for IIH although no trial data is available. Currently underway is a National Eye Institute sponsored study called the Idiopathic Intracranial Hypertension Treatment Trial (IHTT)(http://www.nordicclinicaltrials.com). The IHTT is comparing the efficacy of acetazolamide and placebo in the treatment of IIH in patients with moderate visual loss. VI. Conclusion The annual incidence of IIH is 3.5/100,000 in women 15 to 44 years of age and is increasing in incidence in parallel with the current epidemic of obesity3. In the presence of papilledema IIH is diagnosed by performing neurodiagnostic studies and a lumbar puncture to rule out other causes of increased intracranial pressure. The treatment typically involves serial lumbar punctures, weight loss, and high dose carbonic anyhydrase inhibitors. The last of which is being studied by the IHTT as to its efficacy in treating patients with IIH and moderate vision loss. Patients with IIH should be followed with regular automated visual fields, and dilated fundus exams to monitor both their vision loss and papilledema respectively. References: 1. Corbet JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 1983;33:1386-8 2. De Simone R, Marano E, Fiorillo C, et al. Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci 2005;25(6):342-344 3. Radhakrishnan K, Ahlskog JE, Cross SA, et al. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993;50:78-80. .
Load more

Recommended publications
  • Meeting Materials
    BUSINESS, CONSUMER SERVICES, AND HOUSING AGENCY EDMUND G. BROWN JR., GOVERNOR STATE BOARD OF OPTOMETRY 2450 DEL PASO ROAD, SUITE 105, SACRAMENTO, CA 95834 0 P (916) 575-7170 F (916) 575-7292 www.optometry .ca.gov OPToMi fikY Continuing Education Course Approval Checklist Title: Provider Name: ☐Completed Application Open to all Optometrists? ☐ Yes ☐No Maintain Record Agreement? ☐ Yes ☐No ☐Correct Application Fee ☐Detailed Course Summary ☐Detailed Course Outline ☐PowerPoint and/or other Presentation Materials ☐Advertising (optional) ☐CV for EACH Course Instructor ☐License Verification for Each Course Instructor Disciplinary History? ☐Yes ☐No BUSINESS, CONSUMER SERVICES, AND HOUSING AGENCY GOVERNOR EDMUND G. BROWN JR. ~~ TATE BOARD OF OPTOMETRY }I /~E{:fLi\1 ~1' DELWSO ROAD, SUITE 105, SACRAMENTO, CA 95834 op'i,otii~l~ 1~0-A~ifiF' t\,rffi-7170 F (916) 575-7292 www.optometry.ca.gov EDUCATION COU Rw1t;--ftf""~'-!-J/-i~--,--__:___::...:..::....::~-~ $50 Mandatory Fee APPLICATION ,-~Jg l Pursuant to California Code of Regulations (CCR) § 1536, the Board will app~romv~e~c~ott=nfli1~nuFTT1t;tngn'zeWl:uc~rRif'tf-:~MT~~=ilt,;;,,_J receiving the applicable fee, the requested information below and it has been determined that the course meets criteria specified in CCR § 1536(g). In addition to the information requested below, please attach a copy of the course schedule, a detailed course outline and presentation materials (e.g., PowerPoint presentation). Applications must be submitted 45 days prior to the course presentation date. Please type or print
    [Show full text]
  • Parkinsonian Symptoms in Normal Pressure Hydrocephalus: a Population-Based Study
    http://www.diva-portal.org This is the published version of a paper published in Journal of Neurology. Citation for the original published paper (version of record): Molde, K., Söderström, L., Laurell, K. (2017) Parkinsonian symptoms in normal pressure hydrocephalus: a population-based study. Journal of Neurology, 264(10): 2141-2148 https://doi.org/10.1007/s00415-017-8598-5 Access to the published version may require subscription. N.B. When citing this work, cite the original published paper. Permanent link to this version: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-142915 J Neurol (2017) 264:2141–2148 DOI 10.1007/s00415-017-8598-5 ORIGINAL COMMUNICATION Parkinsonian symptoms in normal pressure hydrocephalus: a population‑based study Karin Molde1 · Lars Söderström1 · Katarina Laurell1 Received: 3 June 2017 / Revised: 17 August 2017 / Accepted: 18 August 2017 / Published online: 6 September 2017 © The Author(s) 2017. This article is an open access publication Abstract It may be challenging to diferentiate normal liberal use of neuroradiological imaging when investigating pressure hydrocephalus (NPH) from neurodegenerative a patient with parkinsonian features. disorders such as Parkinson’s disease. In this population- based study, we wanted to describe the frequency of par- Keywords Normal pressure hydrocephalus · kinsonian symptoms among individuals with and without Hydrocephalus · Parkinsonism · Parkinson’s disease · NPH, and whether the motor examination part of the Unifed UPDRS Parkinson’s Disease Rating Scale (UPDRS-m) score difers between these groups. Furthermore, we wanted to fnd out whether there was a relationship between UPDRS-m score, Introduction NPH symptoms, and radiological signs of NPH.
    [Show full text]
  • Hydrocephalus Patient Information Guide Experience Life Without Boundaries
    Hydrocephalus Patient Information Guide Experience Life Without Boundaries Aesculap Neurosurgery 2 Table of Contents Foreword Page 4 About Us Page 5 What Is Hydrocephalus Page 6 Types Of Hydrocephalus Page 7 What You Should Know Page 8 Diagnosis Page 9 Treatment/Goal/Surgical Procedure Page 10 Complications Page 10 Prognosis/Helpful Sites Page 11 The Aesculap Shunts Page 12 Medical Definitions Page 13 3 Foreword The intention of this booklet is to provide information to patients, family members, caregivers and friends on the subject of hydrocephalus. The information provided is a general overview of the diagnosis and treatment of hydrocephalus and other conditions associated with hydrocephalus. About us History Aesculap AG (Germany) was founded in 1867 by Gottfried Jetter, a master craftsman trained in surgical instrument and cutlery techniques. Jetter’s original workshop, located in Tuttlingen, Germany, is the same location where Aesculap world headquarters resides today. The employee count has increased over the years (3,000+ employees), and the number of instrument patterns has grown from a select few to over 17,000; however, the German standard for quality and pattern consistency remains the same. Prior to 1977, many of the instruments sold in America by competing companies were sourced from Aesculap in Tuttlingen. In response to the United States customer demand for Aesculap quality surgical instruments, Aesculap, Inc. (U.S.) was established in 1977. Headquartered in Center Valley, Pennsylvania, with over one hundred direct nationwide sales representatives, Aesculap, Inc. currently supports the marketing, sales and distribution of Aesculap surgical instrumentation in the U.S. In order to support the company’s continued growth and provide the service and quality which customers have come to expect, Aesculap relocated the corporate offices from San Francisco to Center Valley, Pennsylvania.
    [Show full text]
  • Symptoms and Signs of Progressive Hydrocephalus
    Arch Dis Child: first published as 10.1136/adc.64.1.124 on 1 January 1989. Downloaded from Archives of Disease in Childhood, 1989, 64, 124-128 Symptoms and signs of progressive hydrocephalus M KIRKPATRICK, H ENGLEMAN, AND R A MINNS Department of Neurology, Royal Hospital for Sick Children, Edinburgh SUMMARY The clinical features of 107 cases of children with hydrocephalus and measured raised intraventricular pressure were analysed retrospectively. Fifty one children had recently been diagnosed as having hydrocephalus, and the remainder had had shunts injected to direct the cerebrospinal fluid. The most common symptoms in the group were vomiting, behavioural changes, drowsiness, and headaches. The most common clinical signs were inappropriately increasing occipitofrontal head circumferences, tense anterior fontanelles, splayed sutures, and distension of the scalp veins. Half the infantile cases of hydrocephalus were without symptoms, and a quarter of the cases with cerebrospinal fluid shunts and measured raised intraventricular pressure were without signs. There were no fewer than 33 different clinical signs including several unusual ones, such as macular rash and sweating. We believe that the presentation of hydrocephalus with raised intraventricular pressure is sufficiently variable, unusual, or even absent to justify the direct measurement of intracranial pressure. copyright. The classical adult presentation of raised intracra- cluded (even if there was also hydrocephalus). nial pressure (headache, vomiting, and papil- Those with ventriculitis were also excluded. Table 1 loedemal) is rare in children with progressive shows the underlying aetiologies in the 107 cases. hydrocephalus. There are few studies of the clinical Hydrocephalus associated with spina bifida and presentation of hydrocephalus with raised intracra- idiopathic hydrocephalus were the most common nial pressure either before or after an operation to presentation (65%).
    [Show full text]
  • Idiopathic Intracranial Hypertension: Any Light on the Mechanism of the Raised Pressure?
    J Neurol Neurosurg Psychiatry 2001;71:1–7 1 EDITORIAL Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure? Everyone knows that no one knows the mechanism of the compensatory processes are no longer functioning. Thus increase of intracranial pressure in idiopathic intracranial an increase in cerebral volume with an equivalent hypertension (IIH; also called pseudotumour cerebri; see reduction in CSF volume will obviously not change the table 1 for diagnostic criteria). Does it much matter? After status quo. Over the years investigational techniques of all, for most aVected people IIH is a benign, self limiting every imaginable degree of complexity and invasiveness condition. However, sometimes it is not,1 and current have been used to explore these possibilities in IIH. Many therapies are unsatisfactory. Medical treatment is poor and of the relevant indices such as CSF formation rate, CSF of unproved benefit.23 Surgical interventions (optic nerve outflow resistance, CSF outflow rate, and sagittal sinus sheath fenestration, lumboperitoneal shunting) have ap- pressure can be measured or calculated, but some of the preciable hazards and failure rates.4–10 Moreover, the techniques used require certain assumptions and are mechanism of increase in intracranial pressure in IIH therefore possibly fallible. Particular diYculties exist in might have relevance to raised intracranial pressure and its knowing to what extent the brain is compressible in management in other situations such as meningitis and response to increasing CSF pressure, and to what extent hydrocephalus. the CSF space is expandable. These factors influence CSF outflow resistance calculations in infusion or perfusion Normal intracranial pressure studies.
    [Show full text]
  • National Eye Institute Visual Function Questionnaire (NEI- VFQ25) in Subjects with IIH and Normal Controls
    Title: Correlation of Visual Function and National Eye Institute Visual Function Questionnaire (NEI- VFQ25) in subjects with IIH and normal controls. Melanie Truong, DO OD Introduction and Purpose Aims of the study: 1. To assess contrast sensitivity acuity and rapid eye movements (saccades) as a measure of visual function in Idiopathic Intracranial Hypertension (IIH) patients compared to normal patients using the King-Devick Variable Contrast Acuity Chart and the K-D rapid eye movement. 2. To assess subjects quality of visual function using the National Eye Institute Visual Function Questionnaire (NEI-VFQ25) questionnaire and Supplement as a comparison between IIH subjects and normal controls. 3. To study the correlation between visual function and quality of visual function questionnaire in subjects with IIH compared to normal controls. Contrast sensitivity is a measure of afferent visual system. Contrast sensitivity deficit with preservation of normal Snellen acuity has also been reported in glaucoma, compressive disorders of the anterior visual pathways, retinal diseases, and with cerebral lesions.1 This test is significantly more sensitive than Snellen acuity .1 It is also superior for serial testing in patients as there was significant improvement in contrast scores and papilledema grade but no significant change in Snellen acuity.1 Visual manifestation of IIH can also include parafoveal deficits. This can lead to deficits in spatial frequency contrast sensitivity.1 Contrast sensitivity is abnormal initially and improved with regression of papilledema.2 Since decisions on therapy in IIH are based on the presence and change in visual function, assessing visual acuities is not the most accurate measure of visual status in IIH.
    [Show full text]
  • Central Serous Papillopathy by Optic Nerve Head Drusen
    Clinical Ophthalmology Dovepress open access to scientific and medical research Open Access Full Text Article CASE REPORT Central serous papillopathy by optic nerve head drusen Ana Marina Suelves1 Abstract: We report a 38-year-old man with a complaint of blurred vision in his right eye for the Ester Francés-Muñoz1 previous 5 days. He had bilateral optic disc drusen. Fluorescein angiography revealed multiple Roberto Gallego-Pinazo1 hyperfluorescent foci within temporal optic discs and temporal inferior arcade in late phase. Diamar Pardo-Lopez1 Optical coherence tomography showed bilateral peripapillary serous detachment as well as right Jose Luis Mullor2 macular detachment. This is the first reported case of a concurrent peripapillary and macular Jose Fernando Arevalo3 detachment in a patient with central serous papillopathy by optic disc drusen. Central serous papillopathy is an atypical form of central serous chorioretinopathy that should be considered Manuel Díaz-Llopis1,4,5 as a potential cause of acute loss of vision in patients with optic nerve head drusen. 1 Department of Ophthalmology, La Fe Keywords: central serous papillopathy, peripapillary central serous chorioretinopathy, optic University Hospital, Valencia, Spain; For personal use only. 2Instituto de Investigación Sanitaria, nerve head drusen, peripapillary subretinal fluid Fundación para la investigación, La Fe Hospital, Valencia, Spain; 3Retina and vitreous service, Clínica Introduction Oftalmológica Centro Caracas, Optic nerve head drusen (ONHD) are hyaline material calcificated
    [Show full text]
  • Stroke, TIA, and ICH
    Stroke, TIA, and ICH INTRACRANIAL HEMORRHAGE – ICH Etiology: • Commonest causes are: (a) hypertensive basal ganglion and cerebellar hemorrhages and (b) lobar hemorrhages (usually in the elderly) due to amyloid angiopathy • Secondary causes include: vascular malformations, hemorrhages into brain tumors or ischemic strokes, cerebral venous sinus or cerebral vein thrombosis, and sympathomimetic drugs Investigations: • Blood sugar • CT head +- CT angiography • Spot sign: on CTA, the extravasation of contrast into the hemorrhage indicates ongoing bleeding and high risk for deterioration • Routine blood work to include INR and drug screen Mortality Scores: • ↑ Risk of mortality with: GCS <13, ICH volume > 30 cc, IVH (intraventricular hemorrhage), infratentorial bleeding, age > 80 Treatment: • Airway management especially if GCS < 9 or patient deteriorating – do not allow BP to drop precipitously during intubation – particularly risky if significant ↓ LOC (due to probability of increased ICP and chance that cerebral perfusion pressure will drop) • Pre-treatment with fentanyl to minimize jump in BP • After intubation: sedate with fentanyl and sedatives to minimize jump in BP • Do not let SBP drop < 100 at any point • Reversal of anti-coagulants (do not give platelets to reverse asa/clopidogrel (unhelpful and likely harmful) • Give platelets if absolute count is <50,000 (many neurosurgeons prefer if < 100,000) • Ideal BP is SBP of 140 or minimally less • Minimize risk for ↑ ICP and manage ↑ ICP • No compression to neck • Head of bed elevated to
    [Show full text]
  • Idiopathic Intracranial Hypertension
    IDIOPATHIC INTRACRANIAL HYPERTENSION William L Hills, MD Neuro-ophthalmology Oregon Neurology Associates Affiliated Assistant Professor Ophthalmology and Neurology Casey Eye Institute, OHSU No disclosures CASE - 19 YO WOMAN WITH HEADACHES X 3 MONTHS Headaches frontal PMHx: obesity Worse lying down Meds: takes ibuprofen for headaches Wake from sleep Pulsatile tinnitus x 1 month. Vision blacks out transiently when she bends over or sits down EXAMINATION Vision: 20/20 R eye, 20/25 L eye. Neuro: PERRL, no APD, EOMI, VF full to confrontation. Dilated fundoscopic exam: 360 degree blurring of disc margins in both eyes, absent SVP. Formal visual field testing: Enlargement of the blind spot, generalized constriction both eyes. MRI brain: Lumbar puncture: Posterior flattening of Opening pressure 39 the globes cm H20 Empty sella Normal CSF studies otherwise normal Headache improved after LP IDIOPATHIC INTRACRANIAL HYPERTENSION SYNDROME: Increased intracranial pressure without ventriculomegaly or mass lesion Normal CSF composition NOMENCLATURE Idiopathic intracranial hypertension (IIH) Benign intracranial hypertension Pseudotumor cerebri Intracranial hypertension secondary to… DIAGNOSTIC CRITERIA Original criteria have been updated to reflect new imaging modalities: 1492 Friedman and Jacobsen. Neurology 2002; 59: Symptoms and signs reflect only those of - increased ICP or papilledema 1495 Documented increased ICP during LP in lateral decubitus position Normal CSF composition No evidence of mass, hydrocephalus, structural
    [Show full text]
  • Amaurosis Fugax (Transient Monocular Or Binocular Vision Loss)
    Amaurosis fugax (transient monocular or binocular vision loss) Syndee Givre, MD, PhD Gregory P Van Stavern, MD The next version of UpToDate (15.3) will be released in October 2007. INTRODUCTION AND DEFINITIONS — Amaurosis fugax (from the Greek "amaurosis," meaning dark, and the Latin "fugax," meaning fleeting) refers to a transient loss of vision in one or both eyes. Varied use of common terminology may cause some confusion when reading the literature. Some suggest that "amaurosis fugax" implies a vascular cause for the visual loss, but the term continues to be used when describing visual loss from any origin and involving one or both eyes. The term "transient monocular blindness" is also often used but is not ideal, since most patients do not experience complete loss of vision with the episode. "Transient monocular visual loss" (TMVL) and "transient binocular visual loss" (TBVL) are preferred to describe abrupt and temporary loss of vision in one or both eyes, since they carry no connotation regarding etiology. Transient visual loss, either monocular or binocular, reflects a heterogeneous group of disorders, some relatively benign and others with grave neurologic or ophthalmologic implications. The task of the clinician is to use the history and examination to localize the problem to a region in the visual pathways, identify potential etiologies, and, when indicated, perform a focused battery of laboratory tests to confirm or exclude certain causes. Therapeutic interventions and prognostic implications are specific to the underlying cause. This topic discusses transient visual loss. Other ocular and cerebral ischemic syndromes are discussed separately. APPROACH TO TRANSIENT VISUAL LOSS — By definition, patients with transient visual loss almost always present after the episode has resolved; hence, the neurologic and ophthalmologic examination is usually normal.
    [Show full text]
  • Polycythemia Vera Presenting with Bilateral Papilledema Retinitis
    July - August 2009 Lett ers to the Editor 325 Amjad Salman, Pragya Parmar, vary signiÞ cantly. With the increasing use of MRI in all cases Vanila G Coimbatore, Rajmohan Meenakshisunderam, suspected to be a brain syndrome, CVT has been increasing Nelson Jesudasan A Christdas diagnosed. MRI is now the gold standard in the diagnosis of CVT as rightly done in this case. Institute of Ophthalmology, Joseph Eye Hospital, Tiruchirapalli - 620 001, India Visual loss in CVT maybe due to thrombotic ischemia of any structure of the visual pathway or due to pressure on the optic Correspondence to Dr. Salman Amjad, Institute of Ophthalmology, Joseph Eye Hospital, Tiruchirapalli - 620 001, India. nerve due to the transmitt ed raised intracranial pressure (ICP). E-mail: [email protected] All cases of CVT with visual loss require visual Þ eld analysis and measurement of optic nerve sheath diameter using B-scan References ultrasonography (USG). Visual loss in patients with CVT due to transmitt ed raised ICP (indicated by increased optic nerve sheath 1. Gillies MC, Simpson JM, Billson FA, Luo W, Penfold P, Chua W, et al. diameter on USG) not amenable to medical management is an Safety of an intravitreal injection of triamcinolone: Results from a indication for optic nerve sheath decompression (ONSD). ONSD randomized clinical trial. Arch Ophthalmol 2004;122:336-40. as a treatment option for the visual loss in the left eye should have 2. Thompson JT. Cataract formation and other complications of intravitreal triamcinolone acetonide for macular edema. Am J been off ered to the patient in this case, as it has been shown to [4,5] Ophthalmol 2006;141:629-37.
    [Show full text]
  • Papilledema": Neuroradiologic Evaluation of Optic Disk Protrusion with Dynamic Orbital CT
    681 "Papilledema": Neuroradiologic Evaluation of Optic Disk Protrusion with Dynamic Orbital CT John R. Jinkins 1 Current-generation CT scc·lners enable the visualization in vivo of structures and substructures that were previously unobservable. Certainly the orbit and optic nerve/ sheath complex have demonstrated a great number of pathologic and normal anatomic variations. It has been found in patients with elevated intracranial pressure that what was previously thought to be simple papilledema in fact masks a surprisingly large component of optic papilla protru<;ion, There may be a variable amount of increased intercellular/axonal fluid within tt.. - optic disk in patients with increased intracranial pressure; however, a significant factor in the " swollen disk" is the simple transmission of pressure along the optic nerve sheath to the papilla, causing it to bulge. Further investigations with dynamic CT reveal that there is decreased perfusion of the optic disk in the active phase of severe increased intracranial pressure in patients with papilledema and/or protrusion as compared with normal control subjects. This de­ pressed flow pattern seems to originate subacutely and appears to resolve in certain patients after normalization of the elevated pressure. These findings apparently indicate that clinical intervention in cases of intracranial hypertension to restore the hemodynamic status of the optic disk would be timely, and thereby avert irreversible damage. This suggests and supports the theory that increased intracranial pressure may lead to rapid vision loss by the mechanical mechanism of pressure projected directly to the junction of the optic nerve and optic nerve head, leading to decreased perfusion, ischemia, axonal flow stasis, and resultant optic nerve atrophy.
    [Show full text]